id	sid	tid	token	lemma	pos
dpc-1053	1	1	dermatology	dermatology	NOUN
dpc-1053	1	2	:	:	PUNCT
dpc-1053	1	3	practical	practical	ADJ
dpc-1053	1	4	and	and	CCONJ
dpc-1053	1	5	conceptual	conceptual	ADJ
dpc-1053	1	6	image	image	NOUN
dpc-1053	1	7	letter	letter	NOUN
dpc-1053	2	1	|	|	ADV
dpc-1053	2	2	dermatol	dermatol	ADJ
dpc-1053	2	3	pract	pract	NOUN
dpc-1053	2	4	concept	concept	NOUN
dpc-1053	2	5	2020;10(1):e2020008	2020;10(1):e2020008	NUM
dpc-1053	2	6	1	1	NUM
dpc-1053	2	7	dermatology	dermatology	NOUN
dpc-1053	2	8	practical	practical	ADJ
dpc-1053	2	9	&	&	CCONJ
dpc-1053	2	10	conceptual	conceptual	ADJ
dpc-1053	2	11	case	case	NOUN
dpc-1053	2	12	presentation	presentation	NOUN
dpc-1053	2	13	a	a	DET
dpc-1053	2	14	54	54	NUM
dpc-1053	2	15	-	-	PUNCT
dpc-1053	2	16	year	year	NOUN
dpc-1053	2	17	-	-	PUNCT
dpc-1053	2	18	old	old	ADJ
dpc-1053	2	19	-	-	PUNCT
dpc-1053	2	20	man	man	NOUN
dpc-1053	2	21	diagnosed	diagnose	VERB
dpc-1053	2	22	with	with	ADP
dpc-1053	2	23	a	a	DET
dpc-1053	2	24	deficiency	deficiency	NOUN
dpc-1053	2	25	of	of	ADP
dpc-1053	2	26	interleukin-36	interleukin-36	NOUN
dpc-1053	2	27	receptor	receptor	NOUN
dpc-1053	2	28	antagonist	antagonist	NOUN
dpc-1053	2	29	(	(	PUNCT
dpc-1053	2	30	ditra	ditra	PROPN
dpc-1053	2	31	)	)	PUNCT
dpc-1053	2	32	under	under	ADP
dpc-1053	2	33	anti	anti	ADJ
dpc-1053	2	34	-	-	ADJ
dpc-1053	2	35	interleukin-1	interleukin-1	ADJ
dpc-1053	2	36	therapy	therapy	NOUN
dpc-1053	2	37	with	with	ADP
dpc-1053	2	38	anakinra	anakinra	NOUN
dpc-1053	2	39	(	(	PUNCT
dpc-1053	2	40	described	describe	VERB
dpc-1053	2	41	elsewhere	elsewhere	ADV
dpc-1053	2	42	[	[	X
dpc-1053	2	43	1	1	NUM
dpc-1053	2	44	]	]	PUNCT
dpc-1053	2	45	)	)	PUNCT
dpc-1053	2	46	presented	present	VERB
dpc-1053	2	47	with	with	ADP
dpc-1053	2	48	an	an	DET
dpc-1053	2	49	erythrodermic	erythrodermic	ADJ
dpc-1053	2	50	pustular	pustular	ADJ
dpc-1053	2	51	psoriasis	psoriasis	NOUN
dpc-1053	2	52	5	5	NUM
dpc-1053	2	53	months	month	NOUN
dpc-1053	2	54	after	after	ADP
dpc-1053	2	55	suspension	suspension	NOUN
dpc-1053	2	56	of	of	ADP
dpc-1053	2	57	his	his	PRON
dpc-1053	2	58	biological	biological	ADJ
dpc-1053	2	59	treatment	treatment	NOUN
dpc-1053	2	60	(	(	PUNCT
dpc-1053	2	61	figure	figure	NOUN
dpc-1053	2	62	1a	1a	NOUN
dpc-1053	2	63	)	)	PUNCT
dpc-1053	2	64	.	.	PUNCT
dpc-1053	3	1	anakinra	anakinra	VERB
dpc-1053	3	2	and	and	CCONJ
dpc-1053	3	3	topical	topical	ADJ
dpc-1053	3	4	corticoids	corticoid	NOUN
dpc-1053	3	5	were	be	AUX
dpc-1053	3	6	then	then	ADV
dpc-1053	3	7	initiated	initiate	VERB
dpc-1053	3	8	.	.	PUNCT
dpc-1053	4	1	three	three	NUM
dpc-1053	4	2	days	day	NOUN
dpc-1053	4	3	later	later	ADV
dpc-1053	4	4	,	,	PUNCT
dpc-1053	4	5	a	a	DET
dpc-1053	4	6	halo	halo	NOUN
dpc-1053	4	7	of	of	ADP
dpc-1053	4	8	nonreddened	nonreddened	ADJ
dpc-1053	4	9	skin	skin	NOUN
dpc-1053	4	10	circumscribing	circumscribe	VERB
dpc-1053	4	11	an	an	DET
dpc-1053	4	12	erythematous	erythematous	ADJ
dpc-1053	4	13	pustular	pustular	ADJ
dpc-1053	4	14	plaque	plaque	NOUN
dpc-1053	4	15	was	be	AUX
dpc-1053	4	16	observed	observe	VERB
dpc-1053	4	17	on	on	ADP
dpc-1053	4	18	his	his	PRON
dpc-1053	4	19	right	right	ADJ
dpc-1053	4	20	side	side	NOUN
dpc-1053	4	21	(	(	PUNCT
dpc-1053	4	22	figure	figure	NOUN
dpc-1053	4	23	1b	1b	NUM
dpc-1053	4	24	)	)	PUNCT
dpc-1053	4	25	.	.	PUNCT
dpc-1053	5	1	the	the	DET
dpc-1053	5	2	patient	patient	NOUN
dpc-1053	5	3	showed	show	VERB
dpc-1053	5	4	a	a	DET
dpc-1053	5	5	complete	complete	ADJ
dpc-1053	5	6	clinical	clinical	ADJ
dpc-1053	5	7	response	response	NOUN
dpc-1053	5	8	in	in	ADP
dpc-1053	5	9	the	the	DET
dpc-1053	5	10	following	follow	VERB
dpc-1053	5	11	weeks	week	NOUN
dpc-1053	5	12	.	.	PUNCT
dpc-1053	6	1	teaching	teaching	NOUN
dpc-1053	6	2	point	point	PROPN
dpc-1053	6	3	ditra	ditra	PROPN
dpc-1053	6	4	is	be	AUX
dpc-1053	6	5	an	an	DET
dpc-1053	6	6	autoinflammatory	autoinflammatory	ADJ
dpc-1053	6	7	disorder	disorder	NOUN
dpc-1053	6	8	caused	cause	VERB
dpc-1053	6	9	by	by	ADP
dpc-1053	6	10	mutations	mutation	NOUN
dpc-1053	6	11	in	in	ADP
dpc-1053	6	12	the	the	DET
dpc-1053	6	13	ilrn36	ilrn36	NOUN
dpc-1053	6	14	gene	gene	NOUN
dpc-1053	6	15	,	,	PUNCT
dpc-1053	6	16	characterized	characterize	VERB
dpc-1053	6	17	by	by	ADP
dpc-1053	6	18	abrupt	abrupt	ADJ
dpc-1053	6	19	-	-	PUNCT
dpc-1053	6	20	onset	onset	ADJ
dpc-1053	6	21	episodes	episode	NOUN
dpc-1053	6	22	of	of	ADP
dpc-1053	6	23	generalized	generalized	ADJ
dpc-1053	6	24	pustular	pustular	ADJ
dpc-1053	6	25	psoriasis	psoriasis	NOUN
dpc-1053	6	26	,	,	PUNCT
dpc-1053	6	27	fever	fever	NOUN
dpc-1053	6	28	,	,	PUNCT
dpc-1053	6	29	and	and	CCONJ
dpc-1053	6	30	systemic	systemic	ADJ
dpc-1053	6	31	woronoff	woronoff	NOUN
dpc-1053	6	32	ring	ring	NOUN
dpc-1053	6	33	in	in	ADP
dpc-1053	6	34	deficiency	deficiency	NOUN
dpc-1053	6	35	of	of	ADP
dpc-1053	6	36	interleukin-36	interleukin-36	NOUN
dpc-1053	6	37	receptor	receptor	NOUN
dpc-1053	6	38	antagonist	antagonist	NOUN
dpc-1053	6	39	(	(	PUNCT
dpc-1053	6	40	ditra	ditra	PROPN
dpc-1053	6	41	)	)	PUNCT
dpc-1053	6	42	daniel	daniel	PROPN
dpc-1053	6	43	morgado	morgado	PROPN
dpc-1053	6	44	-	-	PUNCT
dpc-1053	6	45	carrasco,1	carrasco,1	ADJ
dpc-1053	6	46	sebastian	sebastian	PROPN
dpc-1053	6	47	podlipnik,1	podlipnik,1	PROPN
dpc-1053	6	48	josé	josé	PROPN
dpc-1053	6	49	m.	m.	PROPN
dpc-1053	6	50	mascaró	mascaró	PROPN
dpc-1053	6	51	,	,	PUNCT
dpc-1053	6	52	jr1	jr1	PROPN
dpc-1053	6	53	1	1	NUM
dpc-1053	6	54	department	department	NOUN
dpc-1053	6	55	of	of	ADP
dpc-1053	6	56	dermatology	dermatology	NOUN
dpc-1053	6	57	,	,	PUNCT
dpc-1053	6	58	hospital	hospital	NOUN
dpc-1053	6	59	clínic	clínic	PROPN
dpc-1053	6	60	de	de	PROPN
dpc-1053	6	61	barcelona	barcelona	PROPN
dpc-1053	6	62	,	,	PUNCT
dpc-1053	6	63	universitat	universitat	PROPN
dpc-1053	6	64	de	de	PROPN
dpc-1053	6	65	barcelona	barcelona	PROPN
dpc-1053	6	66	,	,	PUNCT
dpc-1053	6	67	spain	spain	PROPN
dpc-1053	6	68	keywords	keyword	NOUN
dpc-1053	6	69	:	:	PUNCT
dpc-1053	6	70	woronoff	woronoff	NOUN
dpc-1053	6	71	ring	ring	NOUN
dpc-1053	6	72	,	,	PUNCT
dpc-1053	6	73	psoriasis	psoriasis	NOUN
dpc-1053	6	74	,	,	PUNCT
dpc-1053	6	75	ditra	ditra	NOUN
dpc-1053	6	76	,	,	PUNCT
dpc-1053	6	77	deficiency	deficiency	NOUN
dpc-1053	6	78	of	of	ADP
dpc-1053	6	79	interleukin-36	interleukin-36	NOUN
dpc-1053	6	80	receptor	receptor	NOUN
dpc-1053	6	81	antagonist	antagonist	NOUN
dpc-1053	6	82	,	,	PUNCT
dpc-1053	6	83	anakinra	anakinra	NOUN
dpc-1053	6	84	citation	citation	NOUN
dpc-1053	6	85	:	:	PUNCT
dpc-1053	6	86	morgado	morgado	PROPN
dpc-1053	6	87	-	-	PUNCT
dpc-1053	6	88	carrasco	carrasco	PROPN
dpc-1053	6	89	d	d	PROPN
dpc-1053	6	90	,	,	PUNCT
dpc-1053	6	91	podlipnik	podlipnik	X
dpc-1053	6	92	s	s	PROPN
dpc-1053	6	93	,	,	PUNCT
dpc-1053	6	94	mascaró	mascaró	PROPN
dpc-1053	6	95	jm	jm	PROPN
dpc-1053	6	96	jr	jr	PROPN
dpc-1053	6	97	.	.	PROPN
dpc-1053	6	98	woronoff	woronoff	PROPN
dpc-1053	6	99	ring	ring	NOUN
dpc-1053	6	100	in	in	ADP
dpc-1053	6	101	deficiency	deficiency	NOUN
dpc-1053	6	102	of	of	ADP
dpc-1053	6	103	interleukin-36	interleukin-36	NOUN
dpc-1053	6	104	receptor	receptor	NOUN
dpc-1053	6	105	antagonist	antagonist	NOUN
dpc-1053	6	106	(	(	PUNCT
dpc-1053	6	107	ditra	ditra	PROPN
dpc-1053	6	108	)	)	PUNCT
dpc-1053	6	109	.	.	PUNCT
dpc-1053	7	1	dermatol	dermatol	NOUN
dpc-1053	7	2	pract	pract	PROPN
dpc-1053	7	3	concept	concept	NOUN
dpc-1053	7	4	.	.	PUNCT
dpc-1053	8	1	2020;10(1):e2020008	2020;10(1):e2020008	X
dpc-1053	8	2	.	.	PUNCT
dpc-1053	8	3	doi	doi	PROPN
dpc-1053	8	4	:	:	PUNCT
dpc-1053	9	1	https://doi.org/10.5826/dpc.1001a08	https://doi.org/10.5826/dpc.1001a08	PROPN
dpc-1053	9	2	accepted	accept	VERB
dpc-1053	9	3	:	:	PUNCT
dpc-1053	9	4	september	september	PROPN
dpc-1053	9	5	5	5	NUM
dpc-1053	9	6	,	,	PUNCT
dpc-1053	9	7	2020	2020	NUM
dpc-1053	9	8	;	;	PUNCT
dpc-1053	9	9	published	publish	VERB
dpc-1053	9	10	:	:	PUNCT
dpc-1053	9	11	december	december	PROPN
dpc-1053	9	12	31	31	NUM
dpc-1053	9	13	,	,	PUNCT
dpc-1053	9	14	2019	2019	NUM
dpc-1053	9	15	copyright	copyright	NOUN
dpc-1053	9	16	:	:	PUNCT
dpc-1053	9	17	©	©	PROPN
dpc-1053	9	18	2019	2019	NUM
dpc-1053	9	19	morgado	morgado	PROPN
dpc-1053	9	20	-	-	PUNCT
dpc-1053	9	21	carrasco	carrasco	PROPN
dpc-1053	9	22	et	et	PROPN
dpc-1053	9	23	al	al	PROPN
dpc-1053	9	24	.	.	PUNCT
dpc-1053	10	1	this	this	PRON
dpc-1053	10	2	is	be	AUX
dpc-1053	10	3	an	an	DET
dpc-1053	10	4	open	open	ADJ
dpc-1053	10	5	-	-	PUNCT
dpc-1053	10	6	access	access	NOUN
dpc-1053	10	7	article	article	NOUN
dpc-1053	10	8	distributed	distribute	VERB
dpc-1053	10	9	under	under	ADP
dpc-1053	10	10	the	the	DET
dpc-1053	10	11	terms	term	NOUN
dpc-1053	10	12	of	of	ADP
dpc-1053	10	13	the	the	DET
dpc-1053	10	14	creative	creative	ADJ
dpc-1053	10	15	commons	common	NOUN
dpc-1053	10	16	attribution	attribution	NOUN
dpc-1053	10	17	license	license	NOUN
dpc-1053	10	18	,	,	PUNCT
dpc-1053	10	19	which	which	PRON
dpc-1053	10	20	permits	permit	VERB
dpc-1053	10	21	unrestricted	unrestricted	ADJ
dpc-1053	10	22	use	use	NOUN
dpc-1053	10	23	,	,	PUNCT
dpc-1053	10	24	distribution	distribution	NOUN
dpc-1053	10	25	,	,	PUNCT
dpc-1053	10	26	and	and	CCONJ
dpc-1053	10	27	reproduction	reproduction	NOUN
dpc-1053	10	28	in	in	ADP
dpc-1053	10	29	any	any	DET
dpc-1053	10	30	medium	medium	NOUN
dpc-1053	10	31	,	,	PUNCT
dpc-1053	10	32	provided	provide	VERB
dpc-1053	10	33	the	the	DET
dpc-1053	10	34	original	original	ADJ
dpc-1053	10	35	author	author	NOUN
dpc-1053	10	36	and	and	CCONJ
dpc-1053	10	37	source	source	NOUN
dpc-1053	10	38	are	be	AUX
dpc-1053	10	39	credited	credit	VERB
dpc-1053	10	40	.	.	PUNCT
dpc-1053	11	1	funding	funding	NOUN
dpc-1053	11	2	:	:	PUNCT
dpc-1053	11	3	none	none	NOUN
dpc-1053	11	4	.	.	PUNCT
dpc-1053	12	1	competing	compete	VERB
dpc-1053	12	2	interests	interest	NOUN
dpc-1053	12	3	:	:	PUNCT
dpc-1053	12	4	the	the	DET
dpc-1053	12	5	authors	author	NOUN
dpc-1053	12	6	have	have	VERB
dpc-1053	12	7	no	no	DET
dpc-1053	12	8	conflicts	conflict	NOUN
dpc-1053	12	9	of	of	ADP
dpc-1053	12	10	interest	interest	NOUN
dpc-1053	12	11	to	to	PART
dpc-1053	12	12	disclose	disclose	VERB
dpc-1053	12	13	.	.	PUNCT
dpc-1053	13	1	authorship	authorship	NOUN
dpc-1053	13	2	:	:	PUNCT
dpc-1053	13	3	all	all	DET
dpc-1053	13	4	authors	author	NOUN
dpc-1053	13	5	have	have	AUX
dpc-1053	13	6	contributed	contribute	VERB
dpc-1053	13	7	significantly	significantly	ADV
dpc-1053	13	8	to	to	ADP
dpc-1053	13	9	this	this	DET
dpc-1053	13	10	publication	publication	NOUN
dpc-1053	13	11	.	.	PUNCT
dpc-1053	14	1	corresponding	correspond	VERB
dpc-1053	14	2	author	author	NOUN
dpc-1053	14	3	:	:	PUNCT
dpc-1053	14	4	josé	josé	PROPN
dpc-1053	14	5	m.	m.	PROPN
dpc-1053	14	6	mascaró	mascaró	PROPN
dpc-1053	14	7	,	,	PUNCT
dpc-1053	14	8	jr	jr	PROPN
dpc-1053	14	9	,	,	PUNCT
dpc-1053	14	10	md	md	PROPN
dpc-1053	14	11	,	,	PUNCT
dpc-1053	14	12	department	department	PROPN
dpc-1053	14	13	of	of	ADP
dpc-1053	14	14	dermatology	dermatology	NOUN
dpc-1053	14	15	,	,	PUNCT
dpc-1053	14	16	hospital	hospital	NOUN
dpc-1053	14	17	clínic	clínic	PROPN
dpc-1053	14	18	de	de	PROPN
dpc-1053	14	19	barcelona	barcelona	PROPN
dpc-1053	14	20	,	,	PUNCT
dpc-1053	14	21	barcelona	barcelona	PROPN
dpc-1053	14	22	,	,	PUNCT
dpc-1053	14	23	spain	spain	PROPN
dpc-1053	14	24	.	.	PUNCT
dpc-1053	15	1	email	email	NOUN
dpc-1053	15	2	:	:	PUNCT
dpc-1053	15	3	josemanuel.mascaro@gmail.com	josemanuel.mascaro@gmail.com	X
dpc-1053	15	4	figure	figure	NOUN
dpc-1053	15	5	1	1	NUM
dpc-1053	15	6	.	.	PUNCT
dpc-1053	15	7	woronoff	woronoff	PROPN
dpc-1053	15	8	ring	ring	NOUN
dpc-1053	15	9	in	in	ADP
dpc-1053	15	10	deficiency	deficiency	NOUN
dpc-1053	15	11	of	of	ADP
dpc-1053	15	12	interleukin-36	interleukin-36	NOUN
dpc-1053	15	13	receptor	receptor	NOUN
dpc-1053	15	14	antagonist	antagonist	NOUN
dpc-1053	15	15	(	(	PUNCT
dpc-1053	15	16	ditra	ditra	PROPN
dpc-1053	15	17	)	)	PUNCT
dpc-1053	15	18	.	.	PUNCT
dpc-1053	16	1	(	(	PUNCT
dpc-1053	16	2	a	a	X
dpc-1053	16	3	)	)	PUNCT
dpc-1053	16	4	widespread	widespread	ADJ
dpc-1053	16	5	erythematous	erythematous	ADJ
dpc-1053	16	6	and	and	CCONJ
dpc-1053	16	7	pustular	pustular	ADJ
dpc-1053	16	8	rash	rash	NOUN
dpc-1053	16	9	on	on	ADP
dpc-1053	16	10	the	the	DET
dpc-1053	16	11	trunk	trunk	NOUN
dpc-1053	16	12	.	.	PUNCT
dpc-1053	17	1	(	(	PUNCT
dpc-1053	17	2	b	b	X
dpc-1053	17	3	)	)	PUNCT
dpc-1053	17	4	halo	halo	NOUN
dpc-1053	17	5	of	of	ADP
dpc-1053	17	6	nonreddened	nonreddened	ADJ
dpc-1053	17	7	skin	skin	NOUN
dpc-1053	17	8	circumscribing	circumscribe	VERB
dpc-1053	17	9	an	an	DET
dpc-1053	17	10	erythematous	erythematous	ADJ
dpc-1053	17	11	pustular	pustular	ADJ
dpc-1053	17	12	plaque	plaque	NOUN
dpc-1053	17	13	on	on	ADP
dpc-1053	17	14	the	the	DET
dpc-1053	17	15	right	right	ADJ
dpc-1053	17	16	side	side	NOUN
dpc-1053	17	17	(	(	PUNCT
dpc-1053	17	18	3	3	NUM
dpc-1053	17	19	days	day	NOUN
dpc-1053	17	20	after	after	ADP
dpc-1053	17	21	initiating	initiate	VERB
dpc-1053	17	22	anakinra	anakinra	NOUN
dpc-1053	17	23	and	and	CCONJ
dpc-1053	17	24	topical	topical	ADJ
dpc-1053	17	25	corticosteroids	corticosteroid	NOUN
dpc-1053	17	26	)	)	PUNCT
dpc-1053	17	27	.	.	PUNCT
dpc-1053	18	1	mailto:josemanuel.mascaro@gmail.com	mailto:josemanuel.mascaro@gmail.com	NOUN
dpc-1053	18	2	2	2	NUM
dpc-1053	18	3	image	image	NOUN
dpc-1053	18	4	letter	letter	NOUN
dpc-1053	18	5	|	|	ADV
dpc-1053	18	6	dermatol	dermatol	ADJ
dpc-1053	18	7	pract	pract	NOUN
dpc-1053	18	8	concept	concept	NOUN
dpc-1053	18	9	2020;10(1):e2020008	2020;10(1):e2020008	NUM
dpc-1053	18	10	references	reference	NOUN
dpc-1053	18	11	1	1	NUM
dpc-1053	18	12	.	.	PUNCT
dpc-1053	19	1	podlipnik	podlipnik	PROPN
dpc-1053	19	2	s	s	PROPN
dpc-1053	19	3	,	,	PUNCT
dpc-1053	19	4	morgado	morgado	PROPN
dpc-1053	19	5	-	-	PUNCT
dpc-1053	19	6	carrasco	carrasco	PROPN
dpc-1053	19	7	d	d	PROPN
dpc-1053	19	8	,	,	PUNCT
dpc-1053	19	9	fustà	fustà	NOUN
dpc-1053	19	10	-	-	PUNCT
dpc-1053	19	11	novell	novell	NOUN
dpc-1053	19	12	x	x	NOUN
dpc-1053	19	13	,	,	PUNCT
dpc-1053	19	14	et	et	PROPN
dpc-1053	19	15	al	al	PROPN
dpc-1053	19	16	.	.	PUNCT
dpc-1053	19	17	dynamics	dynamic	NOUN
dpc-1053	19	18	of	of	ADP
dpc-1053	19	19	plasma	plasma	NOUN
dpc-1053	19	20	cytokines	cytokine	NOUN
dpc-1053	19	21	in	in	ADP
dpc-1053	19	22	a	a	DET
dpc-1053	19	23	patient	patient	NOUN
dpc-1053	19	24	with	with	ADP
dpc-1053	19	25	deficiency	deficiency	NOUN
dpc-1053	19	26	of	of	ADP
dpc-1053	19	27	interleukin-36	interleukin-36	NOUN
dpc-1053	19	28	receptor	receptor	NOUN
dpc-1053	19	29	antagonist	antagonist	NOUN
dpc-1053	19	30	successfully	successfully	ADV
dpc-1053	19	31	treated	treat	VERB
dpc-1053	19	32	with	with	ADP
dpc-1053	19	33	anakinra	anakinra	NOUN
dpc-1053	19	34	.	.	PUNCT
dpc-1053	20	1	br	br	PROPN
dpc-1053	20	2	j	j	PROPN
dpc-1053	20	3	dermatol	dermatol	NOUN
dpc-1053	20	4	.	.	PUNCT
dpc-1053	21	1	2018;178(4):e258	2018;178(4):e258	NUM
dpc-1053	21	2	-	-	PUNCT
dpc-1053	21	3	e260	e260	PROPN
dpc-1053	21	4	.	.	NOUN
dpc-1053	22	1	2	2	NUM
dpc-1053	22	2	.	.	X
dpc-1053	22	3	park	park	PROPN
dpc-1053	22	4	kk	kk	PROPN
dpc-1053	22	5	,	,	PUNCT
dpc-1053	22	6	swan	swan	PROPN
dpc-1053	22	7	jw	jw	PROPN
dpc-1053	22	8	,	,	PUNCT
dpc-1053	22	9	eilers	eilers	PROPN
dpc-1053	22	10	d	d	PROPN
dpc-1053	22	11	,	,	PUNCT
dpc-1053	22	12	tung	tung	NOUN
dpc-1053	22	13	r	r	NOUN
dpc-1053	22	14	,	,	PUNCT
dpc-1053	22	15	koo	koo	PROPN
dpc-1053	22	16	j.	j.	PROPN
dpc-1053	22	17	woronoff	woronoff	PROPN
dpc-1053	22	18	ring	ring	PROPN
dpc-1053	22	19	associated	associate	VERB
dpc-1053	22	20	with	with	ADP
dpc-1053	22	21	adalimumab	adalimumab	NOUN
dpc-1053	22	22	therapy	therapy	NOUN
dpc-1053	22	23	for	for	ADP
dpc-1053	22	24	psoriasis	psoriasis	NOUN
dpc-1053	22	25	.	.	PUNCT
dpc-1053	23	1	cutis	cutis	NOUN
dpc-1053	23	2	.	.	PUNCT
dpc-1053	24	1	2014;93(2):e1	2014;93(2):e1	NUM
dpc-1053	24	2	-	-	PUNCT
dpc-1053	24	3	e2	e2	NOUN
dpc-1053	24	4	.	.	PUNCT
dpc-1053	24	5	involvement	involvement	NOUN
dpc-1053	24	6	.	.	PUNCT
dpc-1053	25	1	the	the	DET
dpc-1053	25	2	woronoff	woronoff	NOUN
dpc-1053	25	3	ring	ring	NOUN
dpc-1053	25	4	is	be	AUX
dpc-1053	25	5	an	an	DET
dpc-1053	25	6	underrecognized	underrecognized	ADJ
dpc-1053	25	7	sign	sign	NOUN
dpc-1053	25	8	of	of	ADP
dpc-1053	25	9	psoriasis	psoriasis	NOUN
dpc-1053	25	10	,	,	PUNCT
dpc-1053	25	11	a	a	DET
dpc-1053	25	12	halo	halo	NOUN
dpc-1053	25	13	of	of	ADP
dpc-1053	25	14	nonerythematous	nonerythematous	ADJ
dpc-1053	25	15	skin	skin	NOUN
dpc-1053	25	16	surrounding	surround	VERB
dpc-1053	25	17	psoriatic	psoriatic	ADJ
dpc-1053	25	18	plaques	plaque	NOUN
dpc-1053	25	19	.	.	PUNCT
dpc-1053	26	1	its	its	PRON
dpc-1053	26	2	pathogenesis	pathogenesis	NOUN
dpc-1053	26	3	is	be	AUX
dpc-1053	26	4	not	not	PART
dpc-1053	26	5	fully	fully	ADV
dpc-1053	26	6	understood	understand	VERB
dpc-1053	26	7	;	;	PUNCT
dpc-1053	26	8	a	a	DET
dpc-1053	26	9	relative	relative	ADJ
dpc-1053	26	10	deficiency	deficiency	NOUN
dpc-1053	26	11	of	of	ADP
dpc-1053	26	12	prostaglandins	prostaglandin	NOUN
dpc-1053	26	13	and	and	CCONJ
dpc-1053	26	14	endoglin	endoglin	NOUN
dpc-1053	26	15	has	have	AUX
dpc-1053	26	16	been	be	AUX
dpc-1053	26	17	reported	report	VERB
dpc-1053	26	18	.	.	PUNCT
dpc-1053	27	1	the	the	DET
dpc-1053	27	2	woronoff	woronoff	NOUN
dpc-1053	27	3	ring	ring	NOUN
dpc-1053	27	4	can	can	AUX
dpc-1053	27	5	occur	occur	VERB
dpc-1053	27	6	after	after	ADP
dpc-1053	27	7	topical	topical	ADJ
dpc-1053	27	8	corticoid	corticoid	NOUN
dpc-1053	27	9	or	or	CCONJ
dpc-1053	27	10	tar	tar	NOUN
dpc-1053	27	11	treatment	treatment	NOUN
dpc-1053	27	12	,	,	PUNCT
dpc-1053	27	13	fumaric	fumaric	ADJ
dpc-1053	27	14	acid	acid	NOUN
dpc-1053	27	15	esters	ester	NOUN
dpc-1053	27	16	,	,	PUNCT
dpc-1053	27	17	phototherapy	phototherapy	NOUN
dpc-1053	27	18	,	,	PUNCT
dpc-1053	27	19	biological	biological	ADJ
dpc-1053	27	20	therapy	therapy	NOUN
dpc-1053	27	21	[	[	X
dpc-1053	27	22	2	2	NUM
dpc-1053	27	23	]	]	PUNCT
dpc-1053	27	24	,	,	PUNCT
dpc-1053	27	25	or	or	CCONJ
dpc-1053	27	26	even	even	ADV
dpc-1053	27	27	in	in	ADP
dpc-1053	27	28	untreated	untreated	ADJ
dpc-1053	27	29	psoriasis	psoriasis	NOUN
dpc-1053	27	30	.	.	PUNCT